SGMT
Sagimet Biosciences·NASDAQ
--
--(--)
--
--(--)
SGMT fundamentals
Sagimet Biosciences (SGMT) released its earnings on Aug 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.32 (YoY -28.00%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.32
-28.00%
Report date
Aug 13, 2025
Earnings Call
7:00 AM on Aug 13, 2025
Meeting link.EPS
Actual | -0.25 | -0.45 | -0.5 | -0.56 | -0.32 |
Forecast | -0.3317 | -0.3881 | -0.6213 | -0.6659 | -0.5083 |
Surprise | +24.63% | -15.95% | +19.52% | +15.90% | +37.05% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
Did Sagimet Biosciences beat or miss consensus estimates last quarter?What is Sagimet Biosciences's latest dividend and current dividend yield?What factors drove the changes in Sagimet Biosciences's revenue and profit?What is the market's earnings forecast for Sagimet Biosciences next quarter?What does Sagimet Biosciences do and what are its main business segments?What were the key takeaways from Sagimet Biosciences's earnings call?What guidance did Sagimet Biosciences's management provide for the next earnings period?What is Sagimet Biosciences's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
